Compare INBX & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INBX | PNTG |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 1.0B |
| IPO Year | 2024 | 2019 |
| Metric | INBX | PNTG |
|---|---|---|
| Price | $100.93 | $34.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $150.00 | $37.00 |
| AVG Volume (30 Days) | ★ 489.3K | 224.0K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.24 |
| Revenue | $1,300,000.00 | ★ $947,705,000.00 |
| Revenue This Year | N/A | $24.72 |
| Revenue Next Year | N/A | $7.61 |
| P/E Ratio | ★ N/A | $143.96 |
| Revenue Growth | ★ 550.00 | 36.31 |
| 52 Week Low | $12.80 | $21.74 |
| 52 Week High | $155.29 | $37.54 |
| Indicator | INBX | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 52.96 |
| Support Level | $99.20 | $28.05 |
| Resistance Level | $153.14 | $35.13 |
| Average True Range (ATR) | 13.75 | 1.92 |
| MACD | -3.93 | -0.05 |
| Stochastic Oscillator | 8.06 | 51.36 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.